Cystic Fibrosis and Oxidative Stress: The Role of CFTR

被引:21
|
作者
Moliteo, Evelina [1 ]
Sciacca, Monica [1 ]
Palmeri, Antonino [1 ]
Papale, Maria [1 ]
Manti, Sara [1 ,2 ]
Parisi, Giuseppe Fabio [1 ]
Leonardi, Salvatore [1 ]
机构
[1] Univ Catania, San Marco Hosp, Dept Clin & Expt Med, Pediat Resp Unit, Viale Carlo Azeglio Ciampi SN, I-95121 Catania, Italy
[2] Univ Messina, Dept Human & Pediat Pathol Gaetano Barresi, Pediat Unit, AOUP G Martino, Via Consolare Valeria 1, I-98124 Messina, Italy
来源
MOLECULES | 2022年 / 27卷 / 16期
关键词
cystic fibrosis; oxidative stress; cystic fibrosis transmembrane conductance regulator; antioxidant; LUNG-DISEASE; GLUTATHIONE; INFLAMMATION;
D O I
10.3390/molecules27165324
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There is substantial evidence in the literature that patients with cystic fibrosis (CF) have higher oxidative stress than patients with other diseases or healthy subjects. This results in an increase in reactive oxygen species (ROS) and in a deficit of antioxidant molecules and plays a fundamental role in the progression of chronic lung damage. Although it is known that recurrent infection-inflammation cycles in CF patients generate a highly oxidative environment, numerous clinical and preclinical studies suggest that the airways of a patient with CF present an inherently abnormal proinflammatory milieu due to elevated oxidative stress and abnormal lipid metabolism even before they become infected. This could be directly related to cystic fibrosis transmembrane conductance regulator (CFTR) deficiency, which appears to produce a redox imbalance in epithelial cells and extracellular fluids. This review aims to summarize the main mechanism by which CFTR deficiency is intrinsically responsible for the proinflammatory environment that characterizes the lung of a patient with CF.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] The Role of Extended CFTR Gene Sequencing in Newborn Screening for Cystic Fibrosis
    Bergougnoux, Anne
    Lopez, Maureen
    Girodon, Emmanuelle
    INTERNATIONAL JOURNAL OF NEONATAL SCREENING, 2020, 6 (01)
  • [32] LUMACAFTOR Corrector of CFTR Folding Treatment of Cystic Fibrosis
    McPhail, G.
    Clancy, J. P.
    DRUGS OF THE FUTURE, 2012, 37 (10) : 717 - 723
  • [33] The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
    Harvey, Caitlyn
    Weldon, Sinead
    Elborn, Stuart
    Downey, Damian G.
    Taggart, Clifford
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [34] Cystic Fibrosis, CFTR, and Colorectal Cancer
    Scott, Patricia
    Anderson, Kyle
    Singhania, Mekhla
    Cormier, Robert
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (08)
  • [35] CFTR and ENaC functions in cystic fibrosis
    Palma, Alejandra G.
    Kotsias, Basilio A.
    Marino, Gabriela I.
    MEDICINA-BUENOS AIRES, 2014, 74 (02) : 133 - 139
  • [36] Role of CFTR, Pseudomonas aeruginosa and Toll-like receptors in cystic fibrosis lung inflammation
    Buchanan, Paul J.
    Ernst, Robert K.
    Elborn, J. Stuart
    Schock, Bettina
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2009, 37 : 863 - 867
  • [37] The role of endothelial cells in cystic fibrosis
    Declercq, M.
    Treps, L.
    Carmeliet, R.
    Witters, P.
    JOURNAL OF CYSTIC FIBROSIS, 2019, 18 (06) : 752 - 761
  • [38] Links between Disease Severity, Bacterial Infections and Oxidative Stress in Cystic Fibrosis
    Galiniak, Sabina
    Molon, Mateusz
    Rachel, Marta
    ANTIOXIDANTS, 2022, 11 (05)
  • [39] Oxidative stress in cystic fibrosis lung disease: an early event, but worth targeting?
    Hector, Andreas
    Griese, Matthias
    Hartl, Dominik
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (01) : 17 - 19
  • [40] Cross-talk between CFTR and sphingolipids in cystic fibrosis
    Dobi, Dorina
    Loberto, Nicoletta
    Bassi, Rosaria
    Pistocchi, Anna
    Lunghi, Giulia
    Tamanini, Anna
    Aureli, Massimo
    FEBS OPEN BIO, 2023, 13 (09): : 1601 - 1614